Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
| In millions, except per share items | Jun-30-23 | Jun-30-22 | Jun-30-21 | Jun-30-20 | Jun-30-19 | Jun-30-18 | Jun-30-17 | Jun-30-16 |
| | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K |
| Revenues: |
| Medical | 301.6 | 212.3 | 143.5 | 197.0 | 205.0 | 175.3 | 125.5 | |
| Energy | 163.3 | 113.0 | 87.8 | 135.4 | 181.7 | 146.5 | 138.0 | |
| Other | 53.2 | 38.1 | 30.2 | 41.6 | 40.6 | 43.1 | 26.3 | 27.4 |
| Other | 2,032.2 | 1,472.9 | 1,214.1 | 1,807.1 | 1,952.9 | 1,792.8 | 1,507.8 | 1,763.5 |
| Total revenues | 2,550.3 | 1,836.3 | 1,475.6 | 2,181.1 | 2,380.2 | 2,157.7 | 1,797.6 | 1,790.9 |
| Revenue growth [+] | 38.9% | 24.4% | -32.3% | -8.4% | 10.3% | 20.0% | 0.4% | -19.6% |
| Medical | 42.1% | 47.9% | -27.2% | -3.9% | 16.9% | 39.7% | | |
| Energy | 44.5% | 28.7% | -35.2% | -25.5% | 24.0% | 6.2% | | |
| Other | 39.6% | 26.2% | -27.4% | 2.5% | -5.8% | 63.9% | -4.0% | |
| Cost of goods sold | 2,213.0 | 1,686.5 | 1,470.4 | 1,822.4 | 1,935.4 | 1,775.4 | 1,496.8 | 1,535.0 |
| Gross profit | 337.3 | 149.8 | 5.2 | 358.7 | 444.8 | 382.3 | 300.8 | 255.9 |
| Gross margin | 13.2% | 8.2% | 0.4% | 16.4% | 18.7% | 17.7% | 16.7% | 14.3% |
| Selling, general and administrative | 204.2 | 174.7 | 180.2 | 201.0 | 203.4 | 193.0 | 176.1 | 173.8 |
| Other operating expenses | | | 4.2 | 29.3 | -11.4 | | | 12.5 |
| EBITDA [+] | 264.1 | 106.5 | -55.6 | 252.3 | 374.3 | 305.9 | 242.5 | 188.9 |
| EBITDA growth | 148.0% | -291.5% | -122.0% | -32.6% | 22.4% | 26.1% | 28.4% | -28.1% |
| EBITDA margin | 10.4% | 5.8% | -3.8% | 11.6% | 15.7% | 14.2% | 13.5% | 10.5% |
| Depreciation | 124.2 | 124.5 | 116.7 | 115.6 | 114.2 | 109.8 | 111.0 | 112.0 |
| EBITA | 139.9 | -18.0 | -172.3 | 136.7 | 260.1 | 196.1 | 131.5 | 76.9 |
| EBITA margin | 5.5% | -1.0% | -11.7% | 6.3% | 10.9% | 9.1% | 7.3% | 4.3% |
| Amortization of intangibles | 6.8 | 6.9 | 6.9 | 8.3 | 7.3 | 6.8 | 6.8 | 7.3 |
| EBIT [+] | 133.1 | -24.9 | -179.2 | 128.4 | 252.8 | 189.3 | 124.7 | 69.6 |
| EBIT growth | -634.5% | -86.1% | -239.6% | -49.2% | 33.5% | 51.8% | 79.2% | -50.5% |
| EBIT margin | 5.2% | -1.4% | -12.1% | 5.9% | 10.6% | 8.8% | 6.9% | 3.9% |
| Non-recurring items [+] | | | 69.4 | 103.1 | 11.4 | | 3.2 | 18.0 |
| Asset impairment | | | 52.8 | 34.6 | | | | 18.0 |
| Unusual expense | | | | | 11.4 | | | |
| Interest expense | 54.1 | 44.9 | 32.7 | 19.8 | 26.0 | 28.3 | 29.8 | 28.0 |
| Interest expense | 54.1 | 44.9 | 32.7 | 19.8 | 26.0 | 28.3 | 29.8 | 28.0 |
| Other income (expense), net [+] | -6.5 | 6.7 | -16.6 | 0.6 | 0.6 | -0.8 | -21.5 | -2.1 |
| Gain (loss) on debt retirement | | -6.0 | -8.2 | | | | | |
| Other | -6.5 | 12.7 | -8.4 | 0.6 | 0.6 | -0.8 | -21.5 | -2.1 |
| Pre-tax income | 72.5 | -63.1 | -297.9 | 6.1 | 216.0 | 160.2 | 70.2 | 21.5 |
| Income taxes | 16.1 | -14.0 | -68.3 | 4.6 | 49.0 | -28.3 | 23.2 | 10.2 |
| Tax rate | 22.2% | 22.2% | 22.9% | 75.4% | 22.7% | | 33.0% | 47.4% |
| Net income | 56.4 | -49.1 | -229.6 | 1.5 | 167.0 | 188.5 | 47.0 | 11.3 |
| Net margin | 2.2% | -2.7% | -15.6% | 0.1% | 7.0% | 8.7% | 2.6% | 0.6% |
| |
| Basic EPS [+] | $1.16 | ($1.01) | ($4.75) | $0.03 | $3.50 | $3.99 | $1.00 | $0.23 |
| Growth | -214.2% | -78.7% | -15343.3% | -99.1% | -12.3% | 299.4% | 325.7% | -78.9% |
| Diluted EPS [+] | $1.15 | ($1.01) | ($4.75) | $0.03 | $3.47 | $3.96 | $1.00 | $0.23 |
| Growth | -213.2% | -78.7% | -15375.0% | -99.1% | -12.3% | 296.9% | 325.6% | -79.0% |
| |
| Dividends per share [+] | $0.80 | $0.80 | $0.80 | $0.80 | $0.80 | $0.72 | $0.72 | $0.72 |
| Growth | 0.0% | 0.0% | 0.0% | 0.0% | 11.1% | 0.0% | 0.0% | 0.0% |
| |
| Shares outstanding (basic) [+] | 48.8 | 48.5 | 48.3 | 48.1 | 47.7 | 47.2 | 47.0 | 48.1 |
| Growth | 0.6% | 0.4% | 0.4% | 0.8% | 1.1% | 0.4% | -2.3% | -8.6% |
| Shares outstanding (diluted) [+] | 49.2 | 48.5 | 48.3 | 48.2 | 48.1 | 47.6 | 47.1 | 48.2 |
| Growth | 1.4% | 0.4% | 0.2% | 0.2% | 1.1% | 1.1% | -2.3% | -8.5% |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|